Nakagawa Saki, Miki Yasuhiro, Miyashita Minoru, Hata Shuko, Takahashi Yayoi, Rai Yoshiaki, Sagara Yasuaki, Ohi Yasuyo, Hirakawa Hisashi, Tamaki Kentaro, Ishida Takanori, Watanabe Mika, Suzuki Takashi, Ohuchi Noriaki, Sasano Hironobu
Department of Surgical Oncology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Breast Cancer Res Treat. 2016 Jan;155(1):65-75. doi: 10.1007/s10549-015-3668-9. Epub 2015 Dec 29.
Invasive ductal and lobular carcinomas (IDC and ILC) are the two most common histological types of breast cancer, and have been considered to develop from terminal duct lobular unit but their molecular, pathological, and clinical features are markedly different between them. These differences could be due to different mechanisms of carcinogenesis and tumor microenvironment, especially cancer-associated fibroblasts (CAFs) but little has been explored in this aspect. Therefore, in this study, we evaluated the status of angiogenesis, maturation of intratumoral microvessels, and proliferation of CAFs using immunohistochemistry and PCR array analysis to explore the differences of tumor microenvironment between ILC and IDC. We studied grade- and age-matched, luminal-like ILC and IDC. We immunolocalized CD34 and αSMA for an evaluation of CAFs and CD31, Vasohibin-1, a specific marker of proliferative endothelial cells and nestin, a marker of pericytes for studying the status of proliferation and maturation of intratumoral microvessel. We also performed PCR array analysis to evaluate angiogenic factors in tumor stromal components. The number of CAFs, microvessel density, and vasohibin-1/CD31 positive ratio were all significantly higher in ILC than IDC but nestin immunoreactivity in intratumoral microvessel was significantly lower in ILC. These results did indicate that proliferation of CAFs and endothelial cells was more pronounced in ILC than IDC but newly formed microvessels were less mature than those in IDC. PCR array analysis also revealed that IGF-1 expression was higher in ILC than IDC. This is the first study to demonstrate the differences of tumor microenvironment including CAFs and proliferation and maturation of intratumoral vessels between ILC and IDC.
浸润性导管癌和小叶癌(IDC和ILC)是乳腺癌两种最常见的组织学类型,一直被认为起源于终末导管小叶单位,但它们的分子、病理和临床特征却明显不同。这些差异可能归因于不同的致癌机制和肿瘤微环境,尤其是癌症相关成纤维细胞(CAFs),但这方面的研究甚少。因此,在本研究中,我们采用免疫组织化学和PCR芯片分析评估血管生成状态、肿瘤内微血管成熟度以及CAFs的增殖情况,以探究ILC和IDC之间肿瘤微环境的差异。我们研究了分级和年龄匹配的管腔样ILC和IDC。我们通过免疫定位CD34和αSMA来评估CAFs,通过免疫定位CD31、增殖内皮细胞的特异性标志物血管抑制素-1和周细胞标志物巢蛋白来研究肿瘤内微血管的增殖和成熟状态。我们还进行了PCR芯片分析以评估肿瘤基质成分中的血管生成因子。ILC中CAFs的数量、微血管密度和血管抑制素-1/CD31阳性率均显著高于IDC,但ILC中肿瘤内微血管的巢蛋白免疫反应性显著低于IDC。这些结果确实表明,ILC中CAFs和内皮细胞的增殖比IDC更明显,但新形成的微血管比IDC中的微血管成熟度更低。PCR芯片分析还显示,ILC中IGF-1的表达高于IDC。这是第一项证明ILC和IDC之间肿瘤微环境差异的研究,包括CAFs以及肿瘤内血管的增殖和成熟情况。